132 related articles for article (PubMed ID: 22716024)
1. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.
Muraoka S; Kume H; Watanabe S; Adachi J; Kuwano M; Sato M; Kawasaki N; Kodera Y; Ishitobi M; Inaji H; Miyamoto Y; Kato K; Tomonaga T
J Proteome Res; 2012 Aug; 11(8):4201-10. PubMed ID: 22716024
[TBL] [Abstract][Full Text] [Related]
2. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.
Narumi R; Murakami T; Kuga T; Adachi J; Shiromizu T; Muraoka S; Kume H; Kodera Y; Matsumoto M; Nakayama K; Miyamoto Y; Ishitobi M; Inaji H; Kato K; Tomonaga T
J Proteome Res; 2012 Nov; 11(11):5311-22. PubMed ID: 22985185
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
4. Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker.
Yin HR; Zhang L; Xie LQ; Huang LY; Xu Y; Cai SJ; Yang PY; Lu HJ
J Proteome Res; 2013 Sep; 12(9):3912-9. PubMed ID: 23909920
[TBL] [Abstract][Full Text] [Related]
5. Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer.
Zhao Y; Jia W; Sun W; Jin W; Guo L; Wei J; Ying W; Zhang Y; Xie Y; Jiang Y; He F; Qian X
J Proteome Res; 2010 Jun; 9(6):3319-27. PubMed ID: 20420461
[TBL] [Abstract][Full Text] [Related]
6. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
[TBL] [Abstract][Full Text] [Related]
7. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
[TBL] [Abstract][Full Text] [Related]
10. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.
DeSouza LV; Romaschin AD; Colgan TJ; Siu KW
Anal Chem; 2009 May; 81(9):3462-70. PubMed ID: 19323455
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.
Liu NQ; Dekker LJ; Stingl C; Güzel C; De Marchi T; Martens JW; Foekens JA; Luider TM; Umar A
J Proteome Res; 2013 Oct; 12(10):4627-41. PubMed ID: 23957277
[TBL] [Abstract][Full Text] [Related]
12. Early diagnostic protein biomarkers for breast cancer: how far have we come?
Opstal-van Winden AW; Vermeulen RC; Peeters PH; Beijnen JH; van Gils CH
Breast Cancer Res Treat; 2012 Jul; 134(1):1-12. PubMed ID: 22179926
[TBL] [Abstract][Full Text] [Related]
13. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
[TBL] [Abstract][Full Text] [Related]
14. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional peptide separation improving sensitivity of selected reaction monitoring-based quantitative proteomics in mouse liver tissue: comparing off-gel electrophoresis and strong cation exchange chromatography.
Schäfer A; von Toerne C; Becker S; Sarioglu H; Neschen S; Kahle M; Hauck SM; Ueffing M
Anal Chem; 2012 Oct; 84(20):8853-62. PubMed ID: 22994301
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins.
Drabovich AP; Diamandis EP
J Proteome Res; 2010 Mar; 9(3):1236-45. PubMed ID: 20070123
[TBL] [Abstract][Full Text] [Related]
17. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
[TBL] [Abstract][Full Text] [Related]
18. Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer.
Yang WS; Moon HG; Kim HS; Choi EJ; Yu MH; Noh DY; Lee C
J Proteome Res; 2012 Feb; 11(2):1078-88. PubMed ID: 22074005
[TBL] [Abstract][Full Text] [Related]
19. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
20. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
